CNSP (CNS Pharmaceuticals Inc) Gunggung Aset Perusahaan

Simbol resmi perusahaan CNS Pharmaceuticals Inc (CNSP)

The price chart on GURU.Markets illustrates the dynamics of total assets, which currently stand at 18.22, correlating with high medical testing expenses and a lack of economies of scale in R&D. CNS Pharmaceuticals (CNSP) is developing a blood-brain barrier-penetrating anthracycline for the treatment of glioblastoma. The business relies on the exclusivity of Berubicine, ensuring stable sales due to the absence of analogues.

Aset Agregat Perusahaan CNS Pharmaceuticals Inc (CNSP): kanggo periode 04.07.2022 - 31.10.2026

Rincian metrik keuangan lan pasar CNS Pharma (CNSP)

- rega saiki lan proyeksi nilai saham:
Bagan kutipan cnspharma.com|CNSP - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Biji pasar CNS Pharmaceuticals Corp|CNSP - Nilai Perusahaan
- rincian nilai buku perusahaan:
Nilai Buku saben Saham CNS Pharmaceuticals|CNSP - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Nilai Buku cnspharma.com|CNSP - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Rasio Total Utang marang Ekuitas CNS Pharmaceuticals|CNSP - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal CNS Pharmaceuticals Corp|CNSP - Utang perusahaan|Rasio utang marang aset resik CNS Pharmaceuticals Corp|CNSP - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan CNS Pharmaceuticals|Likuiditas cepet cnspharma.com
- rincian bathi lan kelipatan pasar:
CNSP - Bathi resik perusahaan
Analisis dhasar perusahaan:cnspharma.com (CNSP)
Barang utama CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals' development of innovative neuro-oncology drugs requires significant resources; therefore, the aggregate of capital and liabilities, reverse-calculated via ROA, reflects the actual scale of the company's material base. This metric measures the financial equilibrium between R&D investments and debt load, allowing investors to assess the balance between operational stability and the risk of profit shortfall through the value of the company's financial assets.

Pesaing wigati

Nilai Total Aset Perusahaan SHPH (shuttlepharma.com)